Want to take quizzes and track your credits?
As we pass the 1-year anniversary of the start of the COVID-19 pandemic, an analysis by Moghadas and colleagues1 considers the value of frequent testing of schoolchildren in reducing community transmission rates. Certainly, the US and many countries find themselves in a stronger position than they were in 2020. In the US, the pace of vaccinations is increasing, and hospitalizations are now declining in most regions. This will lead some to wonder what value school-based testing can bring in the coming months, particularly during the 2021 to 2022 academic year.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
Published: April 23, 2021. doi:10.1001/jamanetworkopen.2021.7850
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Rubin D et al. JAMA Network Open.
Corresponding Author: David Rubin, MD, MSCE, PolicyLab, Children’s Hospital of Philadelphia, 2716 South St, Roberts Bldg, CHOP North, Ste 10123, Philadelphia, PA 19103 (firstname.lastname@example.org).
Conflict of Interest Disclosures: Dr Coffin reported being a member of a data safety monitoring board for Clostridium difficile therapy research done by Merck & Co and serving as an advisor to Genentech about pediatric therapies for COVID. No other disclosures were reported.
You currently have no searches saved.